NOT ALL BATTERIES ARE CREATED EQUAL

InterStim™ Micro with Overdrive™ battery technology presented at the ISC 2020 Satellite Symposium

Alert Indications, Safety, and Warnings

At the core of InterStim™ Micro is Overdrive™ battery technology – a non-traditional lithium-ion battery that shows zero capacity loss at 15 years*, rapid recharging capabilities, and flexible recharging options for your patients. Watch battery experts and physicians discuss the advantages of Overdrive™ battery technology.

THE SCIENCE BEHIND OVERDRIVE™

Watch lithium-ion battery pioneer Jeff Dahn compare traditional lithium-ion batteries to Medtronic Overdrive™ battery technology (14:05).
More information (see more) Less information (see less)

THE ICS 2020 PANEL DISCUSSION

Join our ICS 2020 panel as they discuss Jeff Dahn's research, and the impact of Overdrive™ battery technology on their bladder and bowel control patients (31:28).
More information (see more) Less information (see less)

ONLY MEDTRONIC OVERDRIVE™ battery TECHNOLOGY OFFERS:

Nearly 100% battery capacity at 15 years*

  • Your patients can expect their device to work just as well in 15 years with no change in battery performance.*

faster recharge than traditional lithium-ion batteries

  • Your patients can recharge their device from zero to 100% in less than an hour.†

No risk of battery damage if fully discharged

  • Your patients have the freedom to turn their battery off with the expectation that it will be fully functional when they're ready to turn it back on – even after long periods of time.
DOWNLOAD THE BATTERY GUIDE

EXPLORE   INTERSTIM™ MICRO

The smallest rechargeable implantable neurostimulator for sacral neuromodulation. 

SEE PRODUCT DETAILS

CONNECT WITH US

Get the latest updates about neuromodulation therapies, solutions, and events via email.

SIGN UP NOW

FOLLOW US ON TWITTER

Follow Medtronic Pelvic Health on Twitter for the latest updates on our products and therapies.

FOLLOW US ON TWITTER

The most common adverse events experienced during clinical studies include pain at implant sites, new pain, lead migration, infection, technical or device problems, adverse change in bowel or voiding function, and undesirable stimulation or sensations. Any of these may require additional surgery or cause return of symptoms.

*

Under standard therapy settings.

†

Based on appropriate recharger placement